# Iv Equipment Market > IV Equipment Market Research Report By Product Type (IV Catheters, IV Infusion Pumps, IV Sets, IV Accessories), By End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, Pharmacies), By Application (Oncology, Gastroenterology, Cardiology, Neurology), By Distribution Channel (Direct Sales, Third-Party Distributors, Online Sales) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 3.17% - **2024:** $ 24.12 Billion - **2025:** $ 24.88 Billion - **2035:** $ 34 Billion - **Key Players:** Companies such as Baxter International (US), B. Braun Melsungen AG (DE), Fresenius Kabi AG (DE), Medtronic (US), Smiths Medical (US), Terumo Corporation (JP), ICU Medical (US), Halyard Health (US), Nipro Corporation (JP) are some of the major participants in the global market. **Report ID:** MRFR/HC/30920-HCR · **Pages:** 128 · **Author:** Nidhi Mandole & Kinjoll Dey · **Last Updated:** June 11, 2026 **URL:** https://www.marketresearchfuture.com/reports/iv-equipment-market-32720 --- ## Market Summary ## IV Equipment Market Overview: As per MRFR analysis, the Iv Equipment Market Size was estimated at 24.12 (USD Billion) in 2024. The Iv Equipment Market Industry is expected to grow from 24.88 (USD Billion) in 2025 to 32.96 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 3.17% during the forecast period (2025 - 2034). ### Key IV Equipment Market Trends Highlighted An increasing demand for safe and effective delivery methods of medications, fluids, and nutrients to patients is driving the Global IV Equipment Market. Factors such as the rising prevalence of chronic diseases, growing surgical procedures, and an aging population play a significant role in bolstering this demand. Additionally, advancements in technology are leading to more innovative and efficient IV equipment, further enhancing patient care and safety. The emphasis on improving hospital infrastructure and increasing healthcare expenditure is also propelling market growth. Opportunities within the market lie in the development of smart IV equipment that integrates with electronic health records and monitoring systems.There is a growing interest in devices that can provide real-time data analytics and enhance patient outcomes. Companies can also explore the potential in emerging markets where healthcare infrastructure is rapidly improving. This provides a chance to create customized solutions that cater to the specific needs of these regions. Another area of opportunity is the focus on environmentally friendly products as the healthcare sector moves towards sustainable practices. Recent trends indicate a shift towards the use of IV equipment that offers more than basic functionality. For instance, smart pumps that prevent medication errors and devices that allow for remote monitoring are gaining popularity. As awareness of infection control and patient safety increases, the market for IV equipment continues to evolve, adapting to the changing needs of healthcare professionals and patients. The ongoing research and development efforts aim to streamline IV therapy processes further, indicating a promising future for this essential segment of the healthcare industry. **Source: Primary Research, Secondary Research, MRFR Database and Analyst Review** ## IV Equipment Market Drivers ### Increasing Incidence of Chronic Diseases The Global IV Equipment Market Industry is witnessing a significant growth driven by the increasing incidence of chronic diseases across the globe. Conditions such as diabetes, cancer, and cardiovascular diseases are becoming more prevalent, leading to a greater need for intravenous therapies. These health issues often require long-term treatments, which significantly propel the demand for advanced IV equipment. As healthcare providers seek to improve patient outcomes, they are investing in innovative technologies that enhance the delivery of medications through intravenous methods. This growing focus on chronic disease management is also motivating the development of new, more effective IV administration systems. Furthermore, patient education about the benefits of intravenous therapies has heightened healthcare demand, necessitating more efficient solutions to manage treatment processes. Adequate training and resources for healthcare professionals to use IV equipment safely and efficiently are becoming essential. The expanding elderly population, who are particularly susceptible to chronic conditions, further amplifies this demand. ### Technological Advancements in IV Equipment Technological innovations are a critical driver for the Global IV Equipment Market Industry, as advancements in equipment design and functionality enhance the overall patient experience. The development of smart IV pumps and infusion systems that integrate digital monitoring capabilities has gained immense traction. These advanced devices reduce the chances of administration errors and ensure precise dosage delivery, catering to diverse patient needs. Additionally, the advent of automated IV compounding systems has further streamlined the preparation process of IV solutions, leading to improved efficiency and safety in clinical settings. The evolution of mobile and portable IV devices is also expanding the scope of applications, particularly in home healthcare settings. These technological improvements not only attract healthcare providers but also improve patient satisfaction by providing more comfortable and reliable treatment options. ### Rise in Home Healthcare Services The growing trend of home healthcare services is significantly impacting the Global IV Equipment Market Industry. As patients increasingly prefer to receive care at home rather than in traditional healthcare facilities, there is a rising demand for IV equipment suited for home use. This shift is attributed to the desire for greater comfort, reduced healthcare costs, and a personalized approach to treatment. The need for intravenous therapies at home has prompted manufacturers to design user-friendly, safe, and efficient IV devices tailored for non-professional caregivers.With an increasing number of home healthcare agencies entering the market to meet this demand, the Global IV Equipment Market is poised for considerable growth as it evolves to cater to this emerging segment. ## IV Equipment Market Segment Insights: ### IV Equipment Market Product Type Insights   The Global IV Equipment Market revenue is expected to see substantial growth in the coming years, driven by advancements in technology and increasing healthcare needs. In 2023, the IV Catheters segment held a significant share with a market valuation of 8.5 USD Billion, allowing it to dominate the overall landscape of the Global IV Equipment Market segmentation. By 2032, it is projected to grow to 11.5 USD Billion, reflecting a strong need for efficient and reliable intravenous delivery systems. Moreover, IV Infusion Pumps are also gaining traction, with a market valuation of 6.0 USD Billion in 2023, which is expected to increase to 8.0 USD Billion by 2032, underscoring their vital role in managing patient therapies with precision and safety.Meanwhile, IV Sets are valued at 5.5 USD Billion in 2023 and are forecasted to rise to 7.5 USD Billion in 2032, suggesting a steady demand for these essential accessories that facilitate fluid delivery in clinical environments. IV Accessories, while the smallest segment, with a valuation of 2.66 USD Billion in 2023, poised to reach 3.0 USD Billion by 2032, still contributes significantly by enhancing the overall efficiency and safety of intravenous therapies. The interplay of these components showcases a structured approach to patient care, where each segment plays a crucial role in comprehensive treatment strategies, thus driving overall Global IV Equipment Market growth. Growing awareness and focus on healthcare standards also stimulate investments in advanced IV equipment, highlighting an opportunity for further market expansion. With a mix of evolving demands and the necessity for effective treatment methods, the Global IV Equipment Market continues its trajectory toward sustaining growth and innovation in the forthcoming years. **Source: Primary Research, Secondary Research, MRFR Database and Analyst Review** ### IV Equipment Market End User Insights   The Global IV Equipment Market encompasses various end-user categories, playing a crucial role in its overall dynamics. In 2023, the market was valued at approximately 22.66 USD Billion, reflecting the increasing reliance on intravenous therapies across healthcare settings. Hospitals are a major end user, where IV equipment is fundamental for patient care, enhancing treatment efficiency and outcomes. Similarly, Ambulatory Surgical Centers prominently utilize IV equipment for outpatient procedures, highlighting a trend toward minimally invasive techniques.In-Home Care Settings, the demand for IV equipment has surged due to the growing preference for home healthcare solutions, allowing patients to receive treatments in comfort. Pharmacies also represent a significant segment, as they provide essential IV medications and equipment to patients and healthcare providers, thereby facilitating accessibility. The segmentation within the Global IV Equipment Market data illustrates distinct trends and growth drivers, including an aging population and rising chronic diseases, while challenges may stem from regulatory hurdles and cost pressures.Nonetheless, the overall market growth remains positive, driven by the expanding applications and focus on improving patient care across these sectors, as reflected in Global IV Equipment Market statistics. ### IV Equipment Market Application Insights   The Global IV Equipment Market is experiencing notable growth through various application segments, which significantly contribute to its overall landscape. As of 2023, the market was valued at approximately 22.66 billion USD. Key applications like [Oncology](../../../reports/oncology-information-systems-market-7080), Gastroenterology, Cardiology, and Neurology play essential roles in expanding market opportunities. Oncology is a crucial area due to the increasing prevalence of cancer, necessitating advanced IV equipment for treatment delivery. Gastroenterology's demand is driven by digestive disorders, emphasizing the importance of effective medication administration. Cardiology captures a significant portion of the market as cardiovascular diseases continue to rise, creating urgent needs for innovative IV solutions. Neurology remains vital as neurological conditions become more prevalent, highlighting the growing necessity for specialized IV treatments. The overall market's diverse applications cater to a wide range of medical needs, contributing to the Global IV Equipment Market revenue while being aligned with the ongoing trends of personalized medicine and technological advancements. The consistent focus on enhancing patient care and the increasing adoption of IV therapies reflect strong and promising growth in the Global IV Equipment Market statistics. ### IV Equipment Market Distribution Channel Insights   The Global IV Equipment Market revenue reached 22.66 USD Billion in 2023, showcasing a steady progression in market growth driven by innovations and an increasing demand for healthcare services. Within the distribution channel segment of this market, various approaches, including Direct Sales, Third-Party Distributors, and Online Sales, hold significant importance. Direct Sales typically foster closer relationships between manufacturers and healthcare providers, enhancing communication and customer support. Meanwhile, Third-Party Distributors often dominate the market due to their extensive reach and ability to offer a diverse range of products efficiently to various medical facilities.The rise of Online Sales has introduced a transformative era in the IV Equipment Market industry, providing greater accessibility and convenience for purchasing. The overall Global IV Equipment Market segmentation highlights the dynamic nature of these distribution channels, which play a crucial role in ensuring that healthcare providers can easily access necessary intravenous equipment. The demand across these channels continues to grow, bolstered by the need for efficient medical supplies amid the evolving healthcare landscape while maintaining a focus on quality and reliable service provision. ### IV Equipment Market Regional Insights The Global IV Equipment Market shows a strong presence across various regions, with a total market revenue of 22.66 USD Billion in 2023. North America holds a dominant position, valued at 10.0 USD Billion, which signifies its majority holding in the market due to advanced healthcare infrastructure and high demand for IV devices. Europe follows, valued at 6.0 USD Billion, driven by increasing chronic diseases and a growing elderly population, contributing significant growth in this sector. The APAC region, valued at 4.0 USD Billion, is gaining traction due to rapid urbanization and improved healthcare access, making it a significant player in the future. South America and MEA, though smaller in comparison with valuations of 1.5 USD Billion and 1.16 USD Billion, respectively, still represent emerging opportunities for growth as healthcare standards continue to improve, offering the potential for IV equipment penetration. The Global IV Equipment Market data suggests a drive towards enhancing patient care and innovative devices, while challenges include varying regulatory environments and cost pressures impacting market growth across these regions. **Source: Primary Research, Secondary Research, MRFR Database and Analyst Review** ## IV Equipment Market Key Players and Competitive Insights: The Global IV Equipment Market is characterized by a dynamic competitive landscape where companies strive for innovation, quality, and regulatory compliance to meet the diverse needs of healthcare providers. This market includes a wide range of products, such as IV infusion pumps, catheters, and syringes, which are integral to the administration of medications and fluids to patients. With the growing emphasis on patient safety and effective healthcare delivery, companies in this sector are competing not only on product quality but also on technological advancements and the ability to offer comprehensive solutions tailored to various healthcare settings. The response to evolving healthcare standards, along with increasing demand for home healthcare services, has intensified competition among industry players, compelling them to invest in R&D and develop user-friendly products that enhance patient and operator safety.B. Braun Melsungen has established a strong presence in the Global IV Equipment Market through its commitment to innovation and high-quality products. Strengthened by decades of experience in healthcare, B. Braun has developed a comprehensive portfolio of IV solutions that cater to hospitals, clinics, and outpatient facilities. Their products are recognized for incorporating advanced technology, which aims to improve the efficiency of drug delivery systems while minimizing risks associated with IV therapy. The company's focus on patient and healthcare professional safety is reflected in its design philosophy, often leading to industry-first innovations. B. Braun's strategic collaborations with healthcare providers and involvement in various industry initiatives reinforce its position as a leader in the market, allowing the company to stay ahead of emerging trends and address changing consumer needs effectively.Cardinal Health is a prominent player in the Global IV Equipment Market, known for its extensive distribution network and robust product offerings. The company has forged strong relationships with healthcare providers, making it a trusted partner for IV supply solutions. Cardinal Health's strength lies in its ability to provide a wide range of IV equipment alongside essential supply chain management services, ensuring that healthcare facilities have timely access to necessary products. The company continues to invest in enhancing its IV product line, focusing on safety and ease of use, which are critical for improving patient outcomes. Cardinal Health's dedication to compliance with regulatory standards and its commitment to sustainable practices further bolsters its reputation in the market, allowing it to maintain a competitive edge while addressing the evolving demands of the healthcare industry. ### Key Companies in the IV Equipment Market Include: - Braun Melsungen - Cardinal Health - Halyard Health - IV Solutions - Beechwood Pharmaceuticals - Hollister Incorporated - **[Medtronic](https://www.medtronic.com/en-us/healthcare-professionals/products.html)** - Stryker Corporation - Vygon - Mindray - Terumo Corporation - Fresenius Kabi - Baxter International - McKesson Corporation - Smiths Medical ## Iv Equipment Industry Developments - **Q2 2024: Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump with Dose IQ Safety Software** Baxter received FDA clearance for its Novum IQ Large Volume Infusion Pump with Dose IQ Safety Software, expanding its smart infusion pump portfolio for intravenous medication delivery in the U.S. - **Q2 2024: B. Braun Launches Spaceplus Infusion Pump System in the United States** B. Braun announced the U.S. launch of its Spaceplus Infusion Pump System, designed to enhance intravenous therapy safety and efficiency in hospital settings. - **Q2 2024: Fresenius Kabi Receives FDA 510(k) Clearance for Agilia Connect Infusion System** Fresenius Kabi received FDA 510(k) clearance for its Agilia Connect Infusion System, enabling advanced connectivity and safety features for intravenous medication administration. - **Q1 2024: Smiths Medical Launches CADD-Solis VIP Ambulatory Infusion Pump** Smiths Medical launched the CADD-Solis VIP Ambulatory Infusion Pump, a new device for intravenous drug delivery in home and ambulatory care settings. - **Q2 2024: ICU Medical Announces FDA Clearance for Plum Duo Infusion Pump** ICU Medical received FDA clearance for its Plum Duo Infusion Pump, a dual-channel intravenous infusion device designed to improve workflow and patient safety. - **Q1 2024: Becton Dickinson acquires infusion pump startup Medovate** Becton Dickinson (BD) acquired Medovate, a UK-based startup specializing in smart intravenous infusion pump technology, to expand its IV equipment portfolio. - **Q2 2024: Baxter Opens New IV Bag Manufacturing Facility in North Carolina** Baxter opened a new intravenous (IV) bag manufacturing facility in North Carolina to increase production capacity and meet growing demand for IV solutions in the U.S. - **Q1 2024: Fresenius Kabi Launches Simplist Micro IV Push Pre-Filled Syringes in Europe** Fresenius Kabi launched its Simplist Micro IV Push pre-filled syringes in select European markets, expanding its intravenous medication delivery product line. - **Q2 2024: B. Braun and Omnicell Announce Strategic Partnership to Integrate Infusion Pump Data with Pharmacy Automation** B. Braun and Omnicell entered a strategic partnership to integrate B. Braun’s infusion pump data with Omnicell’s pharmacy automation systems, aiming to improve intravenous medication management. - **Q1 2024: ICU Medical Completes Acquisition of Pursuit Vascular** ICU Medical completed the acquisition of Pursuit Vascular, a company specializing in IV catheter disinfection technology, to enhance its intravenous therapy safety offerings. - **Q2 2024: Baxter International appoints José Almeida as CEO** Baxter International appointed José Almeida as its new Chief Executive Officer, signaling a leadership change at the global IV equipment manufacturer. - **Q1 2024: BD Launches Next-Generation BD Alaris Infusion System in Canada** Becton Dickinson (BD) launched its next-generation BD Alaris Infusion System in Canada, featuring enhanced safety and interoperability for intravenous medication delivery. ### IV Equipment Market Segmentation Insights ### IV Equipment Market Product Type Outlook - IV Catheters - IV Infusion Pumps - IV Sets - IV Accessories ### IV Equipment Market End User Outlook - Hospitals - Ambulatory Surgical Centers - Home Care Settings - Pharmacies ### IV Equipment Market Application Outlook - Oncology - Gastroenterology - Cardiology - Neurology ### IV Equipment Market Distribution Channel Outlook - Direct Sales - Third-Party Distributors - Online Sales ### IV Equipment Market Regional Outlook - North America - Europe - South America - Asia-Pacific - Middle East and Africa ## Market Drivers ### Rising Prevalence of Chronic Diseases The increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer is a primary driver of the IV Equipment Market. As these conditions often require long-term treatment and management, the demand for intravenous therapies is likely to rise. According to recent data, chronic diseases account for approximately 70% of all deaths worldwide, which underscores the necessity for effective treatment options.   This trend compels healthcare providers to invest in advanced IV equipment to ensure efficient and safe delivery of medications. Consequently, the global industry is expected to experience substantial growth as healthcare systems adapt to meet the needs of an aging population and the rising burden of chronic illnesses. - According to the IHME Global Burden of Disease Study, non-communicable diseases account for more than 74% of global deaths annually, creating sustained demand for intravenous drug administration, nutrition support, and long-term treatment management, thereby supporting continuous growth opportunities for advanced IV equipment manufacturers worldwide. ### Technological Innovations in IV Equipment Technological advancements in IV equipment are transforming the landscape of the IV Equipment Market. Innovations such as smart [infusion pumps](https://www.marketresearchfuture.com/reports/infusion-pumps-market-1509), automated IV systems, and advanced catheter technologies enhance the efficiency and safety of intravenous therapies. For instance, smart infusion pumps equipped with dose error reduction systems are becoming increasingly prevalent, reducing the risk of medication errors.   The global market for infusion pumps alone is projected to reach several billion dollars by 2026, indicating a robust growth trajectory. These innovations not only improve patient outcomes but also streamline hospital workflows, making them essential components in modern healthcare settings. As technology continues to evolve, the global industry is poised for further expansion. - According to PubMed, implementation of smart infusion pumps with dose-error reduction software has been shown to reduce medication administration errors by up to 80% in healthcare settings, reinforcing the growing adoption of technologically advanced IV equipment designed to enhance patient safety and operational efficiency. ### Regulatory Compliance and Quality Standards Regulatory compliance and adherence to quality standards are critical drivers in the IV Equipment Market. Governments and health authorities impose stringent regulations to ensure the safety and efficacy of medical devices, including IV equipment. Compliance with these regulations not only enhances patient safety but also fosters trust among healthcare providers and patients.    The global market must navigate complex regulatory landscapes, which can vary significantly across regions. However, companies that successfully meet these standards are likely to gain a competitive advantage. The emphasis on quality assurance and regulatory compliance is expected to shape product development and innovation within the industry, ultimately benefiting patient care. - According to the World Bank, global current health expenditure reached approximately USD 9.8 trillion, reflecting continued investments in quality healthcare systems and regulatory frameworks. This increasing focus on patient safety and medical device quality supports the adoption of compliant, high-performance IV equipment across healthcare facilities worldwide. ### Growing Investment in Healthcare Infrastructure Investment in healthcare infrastructure is a vital driver of the IV Equipment Market. As countries strive to improve their healthcare systems, there is a concerted effort to enhance facilities, expand services, and upgrade medical equipment. This trend is particularly evident in emerging markets, where governments are increasing healthcare spending to meet the demands of growing populations.   For instance, investments in hospitals and clinics are projected to rise significantly, leading to an increased demand for IV equipment. The global market stands to benefit from these investments, as healthcare providers seek to equip their facilities with the latest technologies to improve patient care and operational efficiency. - According to the World Bank, global current health expenditure represented approximately 9.9% of global GDP, highlighting substantial investments in healthcare infrastructure expansion, hospital modernization, and medical equipment procurement, all of which positively contribute to increasing demand for IV equipment. ### Increasing Demand for Home Healthcare Solutions The growing trend towards home healthcare is significantly influencing the IV Equipment Market. Patients increasingly prefer receiving treatments in the comfort of their homes, driven by factors such as convenience, cost-effectiveness, and improved quality of life. This shift necessitates the development of portable and user-friendly IV equipment that can be utilized outside traditional healthcare settings.   Market data suggests that the home healthcare market is expected to grow at a compound annual growth rate of over 7% in the coming years. As a result, manufacturers are focusing on creating innovative IV solutions tailored for home use, thereby expanding their market reach and catering to the evolving needs of patients. - According to PubMed, home-based infusion therapy programs have demonstrated patient satisfaction rates exceeding 90% in multiple clinical studies, supporting the broader transition toward home healthcare and driving demand for portable, easy-to-use intravenous equipment designed for non-hospital environments. ## Future Outlook The IV Equipment Industry size is projected to reach USD 34.0 Billion by 2035, growing at a CAGR of 3.17%, driven by technological advancements, increasing healthcare demands, and enhanced patient care solutions. **New opportunities:** - Development of smart IV infusion pumps with integrated monitoring systems. Expansion into emerging markets with tailored IV solutions. Partnerships with telehealth platforms for remote IV therapy management. By 2035, the IV Equipment Market is expected to be robust, reflecting sustained growth and innovation. ## Segment Insights ### By Product Type: IV Catheters (Largest) vs. IV Infusion Pumps (Fastest-Growing) In the IV Equipment Market, IV Catheters hold the largest market share of 58.4%% due to their critical role in facilitating intravenous access for patients. This segment benefits from extensive applications in healthcare settings, ranging from emergency care to routine procedures. IV Infusion Pumps quickly follow as a significant player, showcasing remarkable adaptability and technological advancement that appeals to healthcare providers seeking precision and ease in patient care. These products are integral in delivering medications, fluids, and nutrition efficiently. Current growth trends suggest that the IV Infusion Pumps segment is poised to experience the fastest growth, driven by increasing demand for automated solutions and the need for enhanced patient safety. Regulatory advancements, rising hospital admissions, and an aging population are key factors propelling this segment forward. Technological innovations, such as smart infusion systems and improved connectivity features, further bolster the growth of infusion pumps in the healthcare sector. Baxter International generated approximately USD 14.8 billion in revenue, supported by its extensive vascular access and infusion therapy portfolio. The company's continued investment in catheter technologies aligns with growing procedural volumes and reinforces the leading position of IV catheters across hospitals and healthcare facilities globally. ### By End User: Hospitals (Largest) vs. Home Care Settings (Fastest-Growing) In the IV Equipment Market, hospitals dominate the end-user segment due to their extensive demand for intravenous therapies in patient care. Hospitals account for the largest share of 67.2%, reflecting their ongoing requirements for diverse intravenous equipment to manage a large volume of patients. On the other hand, ambulatory surgical centers and pharmacies hold smaller shares but are integral components in delivering IV treatments, particularly in outpatient settings. The growth trends in this segment are influenced by several factors, including the increasing prevalence of chronic diseases requiring long-term IV therapy and the rising number of surgical procedures. Home care settings are identified as the fastest-growing segment, driven by a shift towards outpatient care and patient preference for treatment in the comfort of their own homes. This trend is further supported by advancements in IV technology that enhance safety and convenience for patients at home. B. Braun Melsungen AG reported approximately EUR 9.1 billion in annual revenue, reflecting strong demand from hospital-based healthcare services. Increasing inpatient admissions, critical care requirements, and intravenous therapy utilization continue to strengthen hospitals' dominance within the IV Equipment Market. ### By Application: Oncology (Largest) vs. Cardiology (Fastest-Growing) In the IV Equipment Market, the application segments exhibit a diverse distribution of market share. Oncology leads as the largest segment, driven by the increasing prevalence of cancer and the need for effective treatment solutions. This segment encompasses various IV therapies specifically designed for cancer patients, reflecting a significant portion of the market share of 34.6%. In contrast, Gastroenterology and Neurology are smaller segments but contribute to the overall diversity of applications within the IV market, capturing attention due to their specific treatment requirements and innovations. Oncology: Dominant vs. Cardiology: Emerging Oncology stands as the dominant application in the IV Equipment Market, characterized by its essential role in administering therapies for cancer treatment. This segment benefits from a well-established demand for IV solutions tailored to chemotherapy and supportive care. On the other hand, Cardiology is emerging rapidly, reflecting significant growth driven by rising cardiovascular diseases and advancements in treatment methods. Cardiology's focus on innovative IV equipment for therapies such as fluid management and drug delivery is propelling its market presence. Both segments highlight the evolving landscape of the market, showing distinct characteristics and growth potentials. ### By Distribution Channel: Direct Sales (Largest) vs. Online Sales (Fastest-Growing) In the IV Equipment Market, the distribution of market share across different channels indicates a significant lean towards Direct Sales, which currently holds the largest percentage share 61.5%. This dominance is driven by medical facilities and healthcare providers preferring a direct approach for purchasing IV equipment to ensure quality, reliability, and after-sales support. Third-Party Distributors comprise a notable segment as well, providing additional reach and service options, but they are overshadowed by the burgeoning preference for Online Sales, which has gained traction since the pandemic. The growth trends in the distribution channels for IV Equipment are markedly influenced by the rise of e-commerce and digital solutions in healthcare. Online Sales is emerging as the fastest-growing channel, benefiting from increased convenience, the ability to compare products easily, and the expansion of digital health platforms. Conversely, while Direct Sales remains dominant, there is a gradual shift as more institutions explore hybrid models incorporating online purchases alongside traditional methods. This evolution reflects broader healthcare consumption trends, where efficiency and immediacy are increasingly prioritized. Direct Sales (Dominant) vs. Third-Party Distributors (Emerging) The Direct Sales channel in the IV Equipment Market is characterized by strong long-term relationships between manufacturers and healthcare providers, ensuring a steady flow of high-quality equipment and personalized service. This dominance is pivotal for companies who offer specialized products that require technical knowledge and support during sales. In contrast, Third-Party Distributors represent an emerging segment that complements Direct Sales by extending the reach of manufacturers to a broader market. These distributors can offer competitive pricing and access to various equipment options, attracting smaller healthcare facilities or new market entrants. Though still secondary to Direct Sales, the agility and service flexibility of Third-Party Distributors position them as an appealing alternative in a rapidly evolving healthcare landscape. ## Regional Market Share Analysis North America leads in the Iv Equipment Market Size, accounting for over 40.22% of the global revenue in 2024, which signifies its majority holding in the market due to advanced healthcare infrastructure and high demand for IV devices. - According to CDC data, approximately 129 million Americans live with at least one major chronic disease, creating sustained demand for intravenous therapies, infusion services, and hospital-based treatment programs that support North America's leadership position in the IV Equipment Market. Europe Iv Equipment Market size was valued at USD 6.0 Billion in 2024, making it the second-largest regional market with a 24.88% share. - The European Medicines Agency supports a healthcare ecosystem serving more than 448 million people across the European Union, fostering high standards for medical products and intravenous therapies. This robust regulatory environment continues to encourage adoption of advanced IV equipment and supports sustained market growth across Europe. The APAC region, valued at 4.0 USD Billion, is gaining traction due to rapid urbanization and improved healthcare access, making it a significant player in the future. South America and MEA, though smaller in comparison with valuations of 1.5 USD Billion and 1.16 USD Billion, respectively, still represent emerging opportunities for growth as healthcare standards continue to improve, offering the potential for IV equipment penetration. The Global IV Equipment Market data suggests a drive towards enhancing patient care and innovative devices, while challenges include varying regulatory environments and cost pressures impacting market growth across these regions. ## Competitive Benchmarking The Global IV Equipment Industry is characterized by a dynamic competitive landscape where companies strive for innovation, quality, and regulatory compliance to meet the diverse needs of healthcare providers. This market includes a wide range of products, such as IV infusion pumps, catheters, and syringes, which are integral to the administration of medications and fluids to patients. With the growing emphasis on patient safety and effective healthcare delivery, companies in this sector are competing not only on product quality but also on technological advancements and the ability to offer comprehensive solutions tailored to various healthcare settings.    The response to evolving healthcare standards, along with increasing demand for home healthcare services, has intensified competition among industry players, compelling them to invest in R&D and develop user-friendly products that enhance patient and operator safety.B. Braun Melsungen has established a strong presence in the Global IV Equipment Market through its commitment to innovation and high-quality products. Strengthened by decades of experience in healthcare, B. Braun has developed a comprehensive portfolio of IV solutions that cater to hospitals, clinics, and outpatient facilities.   Their products are recognized for incorporating advanced technology, which aims to improve the efficiency of drug delivery systems while minimizing risks associated with IV therapy. The company's focus on patient and healthcare professional safety is reflected in its design philosophy, often leading to industry-first innovations. B. Braun's strategic collaborations with healthcare providers and involvement in various industry initiatives reinforce its position as a leader in the global market, allowing the company to stay ahead of emerging trends and address changing consumer needs effectively.Cardinal Health is a prominent player in the Global IV Equipment Market, known for its extensive distribution network and robust product offerings.    The company has forged strong relationships with healthcare providers, making it a trusted partner for IV supply solutions. Cardinal Health's strength lies in its ability to provide a wide range of IV equipment alongside essential supply chain management services, ensuring that healthcare facilities have timely access to necessary products. The company continues to invest in enhancing its IV product line, focusing on safety and ease of use, which are critical for improving patient outcomes. Cardinal Health's dedication to compliance with regulatory standards and its commitment to sustainable practices further bolsters its reputation in the global market, allowing it to maintain a competitive edge while addressing the evolving demands of the healthcare industry. ## Recent News & Developments - **Q2 2024: Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump with Dose IQ Safety Software** Baxter received FDA clearance for its Novum IQ Large Volume Infusion Pump with Dose IQ Safety Software, expanding its smart infusion pump portfolio for intravenous medication delivery in the U.S. - **Q2 2024: B. Braun Launches Spaceplus Infusion Pump System in the United States** B. Braun announced the U.S. launch of its Spaceplus Infusion Pump System, designed to enhance intravenous therapy safety and efficiency in hospital settings. - **Q2 2024: Fresenius Kabi Receives FDA 510(k) Clearance for Agilia Connect Infusion System** Fresenius Kabi received FDA 510(k) clearance for its Agilia Connect Infusion System, enabling advanced connectivity and safety features for intravenous medication administration. - **Q1 2024: Smiths Medical Launches CADD-Solis VIP Ambulatory Infusion Pump** Smiths Medical launched the CADD-Solis VIP Ambulatory Infusion Pump, a new device for intravenous drug delivery in home and ambulatory care settings. - **Q2 2024: ICU Medical Announces FDA Clearance for Plum Duo Infusion Pump** ICU Medical received FDA clearance for its Plum Duo Infusion Pump, a dual-channel intravenous infusion device designed to improve workflow and patient safety. - **Q1 2024: Becton Dickinson acquires infusion pump startup Medovate** Becton Dickinson (BD) acquired Medovate, a UK-based startup specializing in smart intravenous infusion pump technology, to expand its IV equipment portfolio. - **Q2 2024: Baxter Opens New IV Bag Manufacturing Facility in North Carolina** Baxter opened a new intravenous (IV) bag manufacturing facility in North Carolina to increase production capacity and meet growing demand for IV solutions in the U.S. - **Q1 2024: Fresenius Kabi Launches Simplist Micro IV Push Pre-Filled Syringes in Europe** Fresenius Kabi launched its Simplist Micro IV Push pre-filled syringes in select European markets, expanding its intravenous medication delivery product line. - **Q2 2024: B. Braun and Omnicell Announce Strategic Partnership to Integrate Infusion Pump Data with Pharmacy Automation** B. Braun and Omnicell entered a strategic partnership to integrate B. Braun’s infusion pump data with Omnicell’s pharmacy automation systems, aiming to improve intravenous medication management. - **Q1 2024: ICU Medical Completes Acquisition of Pursuit Vascular** ICU Medical completed the acquisition of Pursuit Vascular, a company specializing in IV catheter disinfection technology, to enhance its intravenous therapy safety offerings. - **Q2 2024: Baxter International appoints José Almeida as CEO** Baxter International appointed José Almeida as its new Chief Executive Officer, signaling a leadership change at the global IV equipment manufacturer. - **Q1 2024: BD Launches Next-Generation BD Alaris Infusion System in Canada** Becton Dickinson (BD) launched its next-generation BD Alaris Infusion System in Canada, featuring enhanced safety and interoperability for intravenous medication delivery. ### IV Equipment Market Segmentation Insights ### IV Equipment Market Product Type Outlook - IV [Catheters](https://www.marketresearchfuture.com/reports/catheters-market-3186) - IV Infusion Pumps - IV Sets - IV Accessories ### IV Equipment Market End User Outlook - Hospitals - Ambulatory Surgical Centers - Home Care Settings - Pharmacies ### IV Equipment Market Application Outlook - Oncology - Gastroenterology - Cardiology - Neurology ### IV Equipment Market Distribution Channel Outlook - Direct Sales - Third-Party Distributors - Online Sales ### IV Equipment Market Regional Outlook - North America - Europe - South America - Asia-Pacific - Middle East and Africa ## Report Scope | MARKET SIZE 2024 | 24.12(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 24.88(USD Billion) | | MARKET SIZE 2035 | 34.0(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 3.17% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Baxter International (US), B. Braun Melsungen AG (DE), Fresenius Kabi AG (DE), Medtronic (US), Smiths Medical (US), Terumo Corporation (JP), ICU Medical (US), Halyard Health (US), Nipro Corporation (JP) | | Segments Covered | Product Type, End User, Application, Distribution Channel, Regional | | Key Market Opportunities | Integration of smart technology in IV Equipment enhances patient monitoring and safety. | | Key Market Dynamics | Rising demand for advanced intravenous equipment drives innovation and competition among manufacturers in the healthcare sector. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the projected market valuation of the IV Equipment Market by 2035?** A: The market is projected to reach a valuation of 34.0 USD Billion by 2035. **Q: What was the market valuation of the IV Equipment Market in 2024?** A: In 2024, the market was valued at 24.12 USD Billion. **Q: What is the expected CAGR for the IV Equipment Market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during the forecast period 2025 - 2035 is 3.17%. **Q: Which product segment is anticipated to have the highest valuation by 2035?** A: By 2035, the IV Infusion Pumps segment is anticipated to reach a valuation of 10.0 USD Billion. **Q: What are the key players in the IV Equipment Market?** A: Key players in the market include Baxter International, B. Braun Melsungen AG, and Fresenius Kabi AG. **Q: How much is the IV Catheters segment projected to be valued at by 2035?** A: The IV Catheters segment is projected to be valued at 8.0 USD Billion by 2035. **Q: What is the expected valuation of the Home Care Settings segment by 2035?** A: The Home Care Settings segment is expected to reach a valuation of 6.0 USD Billion by 2035. **Q: Which application segment is projected to grow the most by 2035?** A: The Cardiology application segment is projected to grow to a valuation of 10.0 USD Billion by 2035. **Q: What distribution channel is expected to have the highest growth by 2035?** A: The Direct Sales distribution channel is expected to grow to 13.0 USD Billion by 2035. **Q: What was the valuation of the IV Accessories segment in 2024?** A: In 2024, the IV Accessories segment was valued at 6.12 USD Billion. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/iv-equipment-market-32720*